the impact of adding low-dose , continuous prednisone ( 7.5 mg/day ) to an adjuvant , chemotherapy regimen of cyclophosphamide , methotrexate , and 5-fluorouracil ( cmf ) was investigated in a randomized trial of 491 premenopausal and perimenopausal patients with operable breast cancer and metastases in 1-3 axillary lymph nodes .
C0025677
methotrexate
C0950521
cmf